Andrew Wang
researcher (ORCID 0000-0002-9781-4494)
Application of liposomal technologies for delivery of platinum analogs in oncologyBiofunctionalized targeted nanoparticles for therapeutic applicationsChemoradiation therapy in the management of gastrointestinal malignanciesClinical Translation of Nanomedicine.Giving failed drugs a fresh chance: a new direction for nanoparticle drug deliveryImproving local control in rectal cancer: radiation sensitizers or radiation dose?Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.Nanomedicine in chemoradiation.Nanoparticle delivery of cancer drugs.Nanoparticle drug delivery: focusing on the therapeutic cargoNanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkersNanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma.Scoring the recurrence score in rectal cancer.
author
Andrew Wang
researcher (ORCID 0000-0002-9781-4494)
gender
type
comment
hulumtues
@sq
researcher (ORCID 0000-0002-9781-4494)
@en
wetenschapper
@nl
изилдөөчү
@ky
հետազոտող
@hy
গবেষক
@bn
研究者
@ja
研究者
@zh
연구원
@ko
label
Andrew Wang
@ast
Andrew Wang
@en
Andrew Wang
@es
Andrew Wang
@nl
Andrew Wang
@sl